J. Goldman & Co »

Amylyx Pharmaceuticals shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 94k 14.72
2023-09-30 $6.4M 350k 18.31
2023-06-30 $2.8M 129k 21.57
2023-03-31 $2.8M 95k 29.34
2022-12-31 $3.7M 100k 36.95